Daniel: A Case for Early Intervention in Pseudomonas aeruginosa Eradication
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
Target Audience
Clinicians involved in treating and managing patients with cystic fibrosis, including pulmonologists, pediatric pulmonologists, gastroenterologists, infectious disease physicians, endocrinologists, pediatricians, nurses, and other members of the cystic fibrosis care team (dieticians, respiratory therapists, social workers, etc).
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Evaluate the pros and cons of early P. aeruginosa eradication.
- Summarize the current evidence basis and expert opinion informing eradication best practices.
- Encapsulate key data from significant eradication trials including ELITE, EPIC and ALPINE.
- Incorporate evidence-based strategies to assess and improve eradication in the early stages of P. aeruginosa infection.
Peter J. Mogayzel, Jr, MD, PhD
Professor, Department of Pediatrics
Director, Johns Hopkins Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
Professor, Department of Pediatrics
Director, Johns Hopkins Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
Margaret Rosenfeld, MD
Professor, Department of Pediatrics
Director, Clinical Research Scholars Program
Associate Director, Center for Clinical and Translational Research
Seattle Children’s Hospital
Seattle, Washington
Harm Tiddens, MD
Professor, Pediatric Pulmonology
Erasmus MC-Sophia Children’s Hospital
Rotterdam, Netherlands
Donna W. Peeler, RN
Pediatric Clinical Coordinator, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
Claire Wainwright, MBBS, MRCP, FRACP, MD
Respiratory Specialist and Head of Cystic Fibrosis Services
Royal Children’s Hospital
Herston, Queensland, Australia
Available Credit
- 1.50 ANCC